| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Bought 98,000 shares
@ $0.51, valued at
$50k
|
|
| 05/19/2023 |
4
| Manting Erik (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.2834, valued at
$12.8k
|
|
| 05/19/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.2834, valued at
$12.8k
|
|
| 05/19/2023 |
4
| Fitzgerald Thomas A (CFO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $0.2834, valued at
$85k
|
|
| 05/19/2023 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 735,000 options to buy
@ $0.2834, valued at
$208.3k
|
|
| 05/19/2023 |
4
| Calais Philippe (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.2834, valued at
$12.8k
|
|
| 05/10/2023 |
4
| Manting Erik (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 9,500 options to buy
@ $0.2985, valued at
$2.8k
|
|
| 05/10/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 9,500 options to buy
@ $0.2985, valued at
$2.8k
|
|
| 05/10/2023 |
4
| Calais Philippe (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 9,500 options to buy
@ $0.2985, valued at
$2.8k
|
|
| 12/14/2022 |
4
| Fitzgerald Thomas A (CFO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.51, valued at
$51k
|
|
| 12/14/2022 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $0.51, valued at
$68.9k
|
|
| 12/14/2022 |
4
| Medarova Zdravka (Chief Technology Officer) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $0.561, valued at
$33.7k
|
|
| 12/14/2022 |
4
| Medarova Zdravka (Chief Technology Officer) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 33,000 options to buy
@ $2.45, valued at
$80.9k
|
|
| 09/16/2022 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.15, valued at
$23k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Fitzgerald Thomas A (CFO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 52,000 options to buy
@ $2.12, valued at
$110.2k
|
|
| 07/08/2021 |
3
| Dudley Robert Michael (CEO) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 07/08/2021 |
3
| Fitzgerald Thomas A (VP, CFO) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 07/08/2021 |
3
| Medarova Zdravka (10% Owner) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 07/08/2021 |
3
| Manting Erik (Director) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 07/08/2021 |
3
| Calais Philippe (Director) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 07/08/2021 |
3
| Moore Anna (10% Owner) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 07/08/2021 |
3
| Marquet Magda (Director) has filed a Form 3 on Transcode Therapeutics, Inc. |